NERV Q3 2020 Earnings — Minerva Neurosciences, Inc. Revenue & Financial Results | Market Cap Arena

NERVMinerva Neurosciences, Inc.

$53M

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$8M

Net Income

-$8M

EPS (Diluted)

$-1.55

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$65M

Total Liabilities

$7M

Stockholders' Equity

$58M

Cash & Equivalents

$33M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$8M	-$14M	+43.4%
Net Income	-$8M	-$14M	+41.9%